Corticosteroids and the treatment idiopathic pulmonary fibrosis: Past, present, and future

Chest

Volumn 110, Issue 4, 1996, Pages 1058-1067

  Mapel, Douglas W ^a,c   Samet, Jonathan M ^b   Coultas, David B ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

corticosteroids; idiopathic pulmonary fibrosis; interstitial lung disease

Indexed keywords

CORTICOSTEROID;

CORTICOSTEROID THERAPY; FIBROSING ALVEOLITIS; HUMAN; LUNG BIOPSY; PRIORITY JOURNAL; REVIEW; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 0029995678     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.110.4.1058     Document Type: Review

References (67)

1. Hamman L, Rich AR. Acute diffuse fibrosis of the lungs. Bull Johns Hopkins Hosp 1944; 74:177-212
2. Homolda J. Idiopathic pulmonary fibrosis: a historical review. Can Med Assoc J 1987; 137:1003-05
3. Olson J, Colby TV, Elliot CG. Hamman-Rich syndrome revisited. Mayo Clin Proc 1990; 65: 1538-48
4. DeRemee RA. Clinical profiles of diffuse interstitial pulmonary disease. Mount Kisco, NY: Futura Publishing, 1990; 149-53
5. Crystal RG. Interstitial lung disease. In: Wyngaarden JB, Smith LH Jr, Claude Bennett JC, eds. Cecil textbook of medicine. 19th ed. Philadelphia: WB Saunders, 1992; 402-03
6. Fulmer JD, Katzenstein AA. The interstitial lung diseases. In: Bone RC, ed. Pulmonary and critical care medicine. St. Louis: Mosby Year Book, 1993; (m-1) 1-15
7. Schwarz MI, King TE Jr. Interstitial lung disease. 2nd ed. St. Louis: Mosby Year Book, 1993; 387-93
8. Reynolds HY. Interstitial lung diseases. In: Isselbacher KJ, Braunwald E, Wilson JD, et al, eds. Harrison's principles of internal medicine. 13th ed. New York: McGraw-Hill, 1994; 1206-09
9. Golden JA. Interstitial (diffuse parenchymal) lung disease: tissue diagnosis and therapy. In: Baum GL, Wolinsky E, eds. Textbook of pulmonary diseases. 5th ed. Boston: Little Brown, 1994; 1072-73
10. Smith CM, Moser KM. Management of interstitial lung disease - state-of-the-art. Chest 1989; 95:676-78
11. Johnston IDA, Gomm SA, Kalra S, et al. The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom. Eur Respir J 1993; 6:891-93
12. Coultas DB, Zunnwalt RE, Black WC, et al. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994; 150:967-72
13. Hunninghake GW, Kalica AR. Workshop summary: approaches to the treatment of pulmonary fibrosis. Am J Respir Crit Care Med 1995; 151:915-18
14. Thorn GW, Jenkins D, Laidlaw JC, et al. Pharmacologic aspects of adrenocortical steroids and ACTH in man. N Engl J Med 1953; 248:284-94,323-37,369-78
15. Rubin EH, Lubliner R. The Hamman-Rich syndrome: review of the literature, and analysis of 15 cases. Medicine 1957; 36:397-463
16. Schechter MM. Diffuse interstitial fibrosis of the lungs. Am Rev Tuberc 1953; 68:603-14
17. Kennedy BJ, Pare JAP, Pump KK, et al. Effect of ACTH on beryllium granulomatosis and silicosis. Am J Med 1951; 10:134-55
18. Siltzbach LE. Effects of cortisone in sarcoidosis: a study of thirteen patients. Am J Med 1952; 12:139-60
19. Carey RA, Harvey AM, Howard JE, et al. The effect of ACTH and cortisone on the course of chronic bronchial asthma. Bull Johns Hopkins Hosp 1950; 87:387-414
20. Peabody JW, Hamman-Rich syndrome: analysis of current concepts and report of three precipitous deaths following cortisone and corticotropin (ACTH) withdrawal. Arch Intern Med 1953; 92:806-24
21. Crystal RG, Gadek JE, Ferrans VJ, et al. Interstitial lung disease: current concepts of pathogenesis, staging and therapy. Am J Med 1981; 70:542-68
22. Silvennan JJ, Talbot TJ. Diffuse interstitial pulmonary fibrosis camouflaged by hypermetabolism and cardiac failure: antemortem diagnosis with biopsy and catheterization studies. Ann Intern Med 1953; 38: 1326-38
23. Pinney CT, Harris HW. Hamman-Rich syndrome: report of a case diagnosed antemortem by lung biopsy and successfully treated with long-term cortisone therapy. Am J Med 1956; 20: 308-13
24. Grant IWB, Hillis BR, Davidson J. Diffuse interstitial fibrosis of the lungs (Hamman-Rich syndrome). Am Rev Tuberc Pulm Dis 1956; 74:485-510
25. Scadding JG. Chronic diffuse interstitial fibrosis of the lungs. BMJ 1960; 1:443-50
26. Herbert FA, Nahmias BB, Gaensler EA, et al. Pathophysiology of interstitial pulmonary fibrorois: report of 19 cases and follow-up with corticosteroids. Arch Intern Med 1962; 110:628-48
27. Read J, Holland RAB. Treatment of the Hamman-Rich syndrome with cortisone. Thorax 1959; 14:71-5
28. Scadding JG. Fibrosing alveolitir [letter]. BM 1964; 2:686
29. Richards DW. Syndrome of alveolar-capillary block. In: Cecil RL, Loeb RF, eds. A textbook of medicine. 10th ed. Philadelphia: WB Saunders, 1959; 972-73
30. Chapman JS. Acute diffuse interstitial fibrosis. In: Harrison TR, ed. Principles of internal medicine. 3rd ed. New York: McGraw-Hill, 1958; 1397
31. Livingstone JL, Lewis JC, Reid L, et al. Diffuse interstitial pulmonary fibrosis: a clinical, radiological, and pathological study based on 45 patients. Q J Med 1964; 33:71-103
32. Stack BHR, Grant IWB, Irvine WJ, et al. Idiopathic difuse interstitial lung disease: a review of 42 cases. Am Rev Respir Dis 1965; 92;939-48
33. Liebow AA, Steer A, Billingsley JG. Desquamative interstitial pneumonia. Am J Med 1965; 39:369-404
34. Scadding JG, Hinson KFW. Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs): correlation of histology at biopsy with prognosis. Thorax 1967; 22:291-304
35. Carrington CB, Gaensler EA, Coutu RE, et al. Natural history and treated course of usual and desquamative interstitial pneunonia. N Engl J Med 1978; 298:801-09
36. Crystal BC, Fulmer JD, Roberts WC, et al. Idiopathic pulmonary fibrosis: clinical, histologic, radiographic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med 1976; 85:769-88
37. Colby TV, Carrington CB. Usual interstitial pneumonia and desquamative interstitial pneumonia. In: Thurlbeck WM, Churg AM, eds. Pathology of the lung. New York: Thieme Medical Publishers, 1995; 600-01
38. Stack BR, Choo-kang YFJ, Heard BE. The prognosis of cryptogenic fibrosing alveolitis. Thorax 1972; 27:535-42
39. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: clinical feutures and their influence on survival. Thorax 1980; 35:171-80
40. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival. Thorax 1980; 35:593-99
41. Tukiainen P, Taskinen E, Holsti P, et al. Prognosis of cryptogenic fibrosing alveolitis. Thorax 1983; 38:349-55
42. Winterbauer RH, Hammar SP, Hallman, et al. Diffuse interstitial pneumonitis: clinicopathologic correlations in 20 patients treated with prednison/azathioprine. Am J Med 1978; 65:661-72
43. Rudd RM, Halsam PL, Turner-Warwick W. Cryptogenic fibrosing alveolitis: relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis 1981; 124:1-8
44. Raghu C, Depaso WJ, Cain K, et al. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled trial. Am Rev Respir Dis 1991; 144:291-96
45. Schwartz DA, Helmers RA, Galvin JR, et al. Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994; 149:450-54
46. Cherniack RM, Crystal RC, Kalica AR. NHLBI workshop summary: current concepts in idiopathic pulmonary fibrosis: a road map for the future. Am Rev Respir Dis 1991; 143:680-83
47. Turner-Warwick M, Halsam PL. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis 1987; 135: 26-34
48. Reynolds HY. Idiopathic interstitial pulmonary fibrosis: contribution of bronchoalveolar lavage analysis. Chest 1986; 89:S139-44
49. Watters LC, King TE, Schwarz MI, et al. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1986; 133:97-103
50. Raghu G. Idiopathic pulmonary fibrosis: a rational clinical approach. Chest 1987; 92:148-54
51. Watters LC, Schwarz MI, Cherniack RM, et al. Idiopathic pulmonary fibrosis: pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis 1987; 135:696-704
52. du Bois, RM. Management of fibrosing alveolitis. Br J Hosp Med 1992; 47:680-83
53. Winterbuner, RH. The treatment of idiopathic pulmonary fibrosis. Chest 1991; 100:233-35
54. Gracey D, Divertie MB. Corticosteroid treatment of diffuse interstitial pulmonary fibrosis. JAMA 1970; 211:495-97
55. Murray JF. Diffuse infiltrative diseases of the lung. In: Wintrobe MM, Thorn CAV, Adams RD, et al, eds. Harrison's principles of Internal medicine. 7th ed. New York: McCraw-Hill, 1974; 1297
56. Smith CM, Holbrook T. Utilization of the transbronchial biopsy and open lung biopsy for tissue to establish the diagnosis of idiopathic pulmonary fibrosis: survey of the California Thoracic Society membership [abstract]. Am Rev Respir Dis 1990; 141:A62
57. Patel R, Picchi MA, Ries AL, et al. Comparison of community-based and academic pulmonary physicians in diagnosis and management of idiopathic pulmonary fibrosis [abstract]. Am J Respir Grit Care Med 1995; 151:A692
58. Smith GM, Picchi MA. Age is a bias in the care of patients with IPF [abstract]. Am J Respir Crit Care Med 1995: 151:A692
59. Eddy DM. Anatomy of a decision. JAMA 1990; 263:441-43
60. Costabel U. Management of idiopathic pulmonary fibrosis: academic postulate and clinical practice. Eur Respir J 1993; 6:770-71
61. Cherniack RM, Colby TV, Flint A, et al. Correlation of structure and function in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1995; 151:1180-88
62. Orens JB, Kazerooni EA, Martinez FJ, et al. The sensitivity of high-resolution CT in detecting idiopathic pulmonary fibrosis proved by open lung biopsy: a prospective study. Chest 1995; 108: 109-15
63. Panos RJ, Mortenson RL, Niccoli SA, et al. Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am J Med 1990; 88:396-404
64. Goldstein RH, Fine A. Potential therapeutic initiatives for fibrogenic lung diseases. Chest 1995; 108:848-55
65. Coultas DB. Epidemiology of idiopathic pulmonary fibrosis. Semin Respir Med 1993; 14:181-96
66. Lee ET. Statistical methods for survival data analysis. New York: John Wiley, 1992; 333-42
67. Warner KE. Treatment decision making in catastrophic illness. Med Care 1977; 15:19-33